Psilocybin Therapy for Bipolar Disorder

‎

Scott Aaronson (Institute for Advance Diagnostics & Therapeutics), Tammy Miller (Institute for Advance Diagnostics & Therapeutics), and Alexandria Pecoraro (University of Maryland)

Tuesday 16 April, 8PM CET (7PM GMT, 2PM EST, 11AM PST)

Online (OPEN Community Platform)

Researchers at Maryland University have completed an early phase clinical trial to assess the feasibility and preliminary outcomes of treating Bipolar II Disorder with single-dose synthetic psilocybin. Specifically, this recently published study treated patients with a BD II diagnosis in a current depressive episode, excluding those in the manic phase of the disorder. The lead researcher Scott Aaronson, and the study’s lead therapist, Tammy Miller, will present the study’s findings and be available for questions from all of you. This is an excellent opportunity to learn about the world’s first psychedelic therapy trial for people with a bipolar disorder, a patient population that is consistently excluded from these trials for fear of inducing new (hypo)manic or psychotic episodes. A novel application indeed!

READY TO ATTEND?

ATTEND FOR FREE AS A MEMBER

Unlock access to this and all exclusive events with leading psychedelic experts and engage in real time through the OPEN Community Membership. Plus, enjoy a community space, a content library, discounts, and more.

ATTEND WITH A SMALL DONATION

Not ready to become an OPEN community member? You can attend this event through a small one-time donation to help support the OPEN Foundation, a leading nonprofit dedicated to advancing psychedelic research since 2007.

Really want to attend but can’t afford a donation? Apply for a one-time free access here.

ABOUT THE SPEAKERS

Dr. Scott Aaronson is a thought leader in the areas of biological psychiatry, diagnosis, and the integration of somatic and psychological therapies. He is an adjunct professor of psychiatry at the University of Maryland School of Medicine, distinguished life fellow of the American Psychiatric Association, and is a fellow of the American College of Psychiatrists. Dr. Aaronson also serves on the board of the American Society of Clinical Psychopharmacology. He graduated with honors from Harvard Medical School and completed his psychiatric residency at McLean Hospital.

Tammy Miller is a clinical psychologist that works full time in the Sheppard Pratt Institute for Advance Diagnostics and Therapeutics. She is the lead psychotherapist for the psilocybin research trials being conducted at Sheppard Pratt. She serves as a mentor to other psilocybin therapist and has been a trainer in psilocybin therapy. Tammy has prior experience working in crisis work, outpatient community health, inpatient hospitals, and private practice. Tammy knew that she wanted to make a meaningful positive contribution to society and discovered her passion in working in mental health and helping others. She is particularly grateful to be part of the team of researchers at Sheppard Pratt who is studying innovative ways to help treat difficult to treatment mental illnesses. When not working you can find Tammy spending time with her family, listening to music, and traveling.

Alexandria Pecoraro participated in a Single Dose Psilocybin trial for Bipolar 2 in the spring of 2022. She is currently a PhD candidate and collegiate educator in the field of ethnomusicology conducting research on singing and social justice in the Washington DC area. Pecoraro is excited to share her experience as a participant in this trial.

Diamond Drip is a trial participant in the Single Dose Psilocybin trial for Bipolar II. She works as a spiritual growth coach. Diamond coaches women leaders and entrepreneurs how to change the old stories they tell themselves. Stories that stem from programmed patterns of fear and self-doubt. She empowers them with tools to help them tap into their intuition, build trust in themselves, and make more confident aligned decisions.

WHAT'S UNIQUE ABOUT THIS EVENT?

Attending this online event is an interactive experience, unlike watching a lecture on YouTube or a webinar. You'll have the chance to connect with the speakers directly and ask questions, allowing you to explore the topic in greater depth.

READY TO ATTEND?

ATTEND FOR FREE AS A MEMBER

ATTEND WITH A SMALL DONATION

Really want to attend but can’t afford a donation? Apply for a one-time free access here.

ALREADY A MEMBER?

To access the OPEN Community Platform, click the button below. The platform not only live streams all events, but also provides direct access to event recordings.